PPBT ▼ -14.5% - Purple Biotech Ltd
$PPBT - Purple Biotech's IM1240, a CAPTN-3-Capped Tri-Specific T- and NK-Cell Engager Targeting 5T4, Shows Robust Tumor Killing in Immunotherapy-Resistant Cancer Models in Plenary Oral Presentation at EORTC-NCI-AACR Symposium
20-NOV-2026 09:00 AM ET
Share this post
More filings for $PPBT
PPBT ▼ -7.7% - Purple Biotech LtdNov 17, 2026PPBT - Purple Biotech Ltd - SEC Filing Update (12-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 12, 2026PPBT - Purple Biotech Ltd - SEC Filing Update (10-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 10, 2026PPBT ▼ -6.2% - Purple Biotech LtdOct 29, 2026PPBT ▲ +18.5% - Purple Biotech LtdSep 2, 2026PPBT - Purple Biotech Ltd - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026
View full $PPBT filing history →💬 Comments
Loading comments…
Leave a comment
